Turoctocog alfa 在中国重型血友病A经治疗患者中预防和治疗出血的有效性：guardian 7 (NCT02938585)

ITP诊疗研究

MDT管理对血友病A规范治疗的影响作用

Fludarabine in combination with Busulfan as pretransplant conditioning for platelet gene therapy in murine Hemophilia A with inhibitors

AdipoRon通过AMPK和PI3K/Akt信号通路抑制血小板活化和血栓形成

Reduced intracellular antioxidant capacity in platelets contributes to development of primary immune thrombocytopenia via ROS-NLRP3-caspase-1 pathway

Clinical Characteristics and Risk Factors of Hepatic Sinusoidal Obstruction Syndrome in Patients Following haploidentical Hematopoietic Stem Cell Transplantation

Incidence of factor VIII and IX inhibitors in hemophilia A and B in China

通过特异性抑制肝素辅因子II重建血友病凝血平衡的研究

血小板相关抗体和淋巴细胞亚群在急性白血病化疗所致血小板减少症中血小板输注无效患者表达的研究

“蔡氏”血友病甲药代动力检测工具的应用与临床验证 （附三种FVIII药代动力学计算方法结果比较）

基于免疫识别的靶向血小板载药体系治疗ITP的作用及机制研究

血友病A抑制物形成风险预测模型的构建

Effect of thrombopoietin receptor agonists on regulation of immune homeostasis and its clinical predictive value in patients with chronic refractory ITP

Bleeds and imaging scoring scales in relation to pharmacokinetics of coagulation factor VIII in Chinese pediatric patients with severe hemophilia A

TPO通过修复化疗后骨髓内皮祖细胞促进巨核细胞造血的作用机制研究

Mucin mutations and aberrant expression are associated with the pathogenesis of immune thrombocytopenia